Technology That Permits Focal Dose of Antibiotics to be Delivered to Lower Limb(s) of Diabetic Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

February 28, 2015

Study Completion Date

March 31, 2015

Conditions
DiabetesInfection
Interventions
PROCEDURE

Percutaneous Isolated Limb Perfusion (PILP) delivery

The Percutaneous Isolated Limb Perfusion (PILP) delivery intervention procedure enables the use of existing antibiotic therapies in a more targeted and aggressive fashion; it addresses limitations associated with the use of conventional antibiotic drug delivery. As part of the procedure, the circulation of the limb is isolated separately from the general circulatory system enabling the delivery of antibiotic at high therapeutic doses that are not achievable when standard doses are administered intravenously.

DRUG

Timentin

The Control Group will receive standard dosings of intravenous Timentin plus other standard care.

Trial Locations (1)

3050

Royal Melbourne Hospital, Parkville

Sponsors
All Listed Sponsors
lead

Osprey Medical, Inc

INDUSTRY